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ABSTRACT Chitin,apolymerof N-acetylglucosamine,isanessentialcomponentofthefungalcellwall.Chitosan,adeacetylated
form of chitin, is also important in maintaining cell wall integrity and is essential for Cryptococcus neoformans virulence. In
theirarticle,Gilbertetal.[N.M.Gilbert,L.G.Baker,C.A.Specht,andJ.K.Lodge,mBio3(1):e00007-12,2012]demonstratethat
theenzymeresponsibleforchitosansynthesis,chitindeacetylase(CDA),isdifferentiallyattachedtothecellmembraneandwall.
Bioactivityislocalizedtothecellmembrane,whereitiscovalentlylinkedviaaglycosylphosphatidylinositol(GPI)anchor.Find-
ingsfromthisstudysigniﬁcantlyenhanceourunderstandingofcryptococcalcellwallbiology.Besidestheroleofchitininsup-
portingstructuralstability,chitinandhostenzymeswithchitinaseactivityhaveanimportantroleinhostdefenseandmodifying
theinﬂammatoryresponse.Thus,chitinappearstoprovidealinkbetweenthefungusandhostthatinvolvesbothinnateand
adaptiveimmuneresponses.Recently,therehasbeenincreasedattentiontotheroleofchitinasesinthepathogenesisofallergic
inﬂammation,especiallyasthma.Wereviewtheseﬁndingsandexplorethepossibleconnectionbetweenfungalinfections,the
inductionofchitinases,andasthma.
CHITIN AND THE FUNGAL CELL WALL
The fungal cell wall is a complex organelle that is a composite of
glucan and chitin ﬁbers held together by proteins and mannan.
The second most common polysaccharide in the environment,
chitin, is a polymer of N-acetylglucosamine. The content and lo-
calizationofchitinvaryamongthefungi.Thoughtheprimaryrole
of chitin appears to be related to its role in structural integrity
(including responses to environmental changes and replication),
other roles have been hypothesized, including epithelial adhesion
(1,2),linkagebetweenthecellwallandcapsule(3),andantifungal
resistance (4). Chitosan is the deacetylated form of chitin and has
been investigated as a vehicle for a variety of therapeutics. In re-
cent studies, chitosan has been shown to be essential for cell wall
integrity and virulence for Cryptococcus neoformans (5).
In their article, Gilbert et al. (6) explore the mechanisms by
which chitin deacetylase (CDA), the enzyme responsible for chi-
tosanproduction,islinkedtothefungalcellwall.Theauthorsﬁnd
thatCDAispresentinboththecellwallandthecellmembranebut
that the attachment mechanism is organelle speciﬁc, so that cell
membrane attachment but not cell wall attachment is dependent
oncovalentbindingviaaglycosylphosphatidylinositol(GPI)link-
age. Importantly, biological activity correlates with the cell
membrane-associated CDA. A noncovalent association between
CDA and the cell wall is distinct from the mechanism previously
elucidatedforthephospholipaseofC.neoformans(7)butparallels
the description for an acid phosphatase of Aspergillus fumigatus
(8).Findingsfromthisstudyprovideimportantnewinsightsinto
chitin biology and mechanisms by which proteins are associated
with the external surface of C. neoformans. The connection of
chitin not to the cell, but to the host response and inﬂammation,
has also garnered signiﬁcant interest.
CHITIN AS AN IMMUNE MODULATOR
Given the importance of chitin to a variety of pathogens, it makes
sense that humans have evolved mechanisms to recognize and
respond to chitin exposures. However, studies attempting to elu-
cidate the type of inﬂammation that chitin elicits have yielded
conﬂictingresults.Earlystudieshighlightedtheimmunoadjuvant
activities of chitin and indicated that chitin and chitin derivatives
(partially deacetylated chitin) induced interleukin-1 (IL-1) ex-
pressionandincreasedantibodyproductionandantitumoractiv-
ity,althoughtheextentoftheseactivitieswasaffectedbythechitin
preparation (9, 10). Consistent with these ﬁndings of enhanced
TH1 inﬂammation, inoculation of chitin and chitosan particles
ameliorated allergic inﬂammation in murine models of asthma
(11). In direct contrast with these ﬁndings, recent studies suggest
that chitin induces TH2 inﬂammation by enhancing accumula-
tionofeosinophilsandbasophilswithintheairways(12,13).Still,
some studies have suggested that chitin is proinﬂammatory, lead-
ing to enhanced IL-17A expression by macrophages via a TLR2-
dependent mechanism (14). Finally, some studies have attributed
anti-inﬂammatory properties to chitin, including the inhibition
of T cell proliferation (15) and blockage of dectin 1-mediated
inﬂammation(16).Thebasisfortheseconﬂictingﬁndingsregard-
ingtheinﬂammatorypropertiesofchitinisnotknownbutmaybe
related to differences in the sizes of chitin particles (17) and
amounts and modes of administration and to differences in poly-
mer structures.
ANTIFUNGAL ACTIVITY OF CHITINASE
Mammalian cells do not contain chitin, but they do produce sev-
eral forms of chitinases with chitinolytic activity, including chito-
triosidase (CHIT1), acidic mammalian chitinase (AMCase), and
other chitinases that apparently lack activity, like YKL-40. Chiti-
nases with chitinolytic activity are thought to play a role in the
innate immune response to fungal and parasitic infections.
CHIT1 is produced by activated macrophages, and elevated levels
of CHIT1 in serum are present in humans during infection, in-
cluding but not limited to fungal infections (18). AMCase is ex-
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and elevated serum chitotriosidase levels were present in guinea
pigs with systemic aspergillosis (20). CHIT1 inhibits fungal
growthbothinvitroandinvivo(21).IncreasedCHIT1expression
isprotectiveinmurinemodelsoffungalinfection,includingcryp-
tococcosis (22). Transgenic plants that overexpress chitinase and
areresistanttofungalinfectionshavebeendeveloped(23).None-
theless, the relative contribution of this enzyme to the host re-
sponsetofungalinfectionremainstobedetermined.Itisconceiv-
able that the role of chitinase in the host response is fungal type
speciﬁc and also related to the host immune status.
CHITINASES AND ALLERGIC INFLAMMATION
Independent of their role in host defense, chitinases have been
increasingly recognized for their role as mediators of allergic in-
ﬂammation. Early studies in mice demonstrated that Ym1 and
Ym2 (murine-speciﬁc chitinases) and AMCase are induced in an
experimental model of asthma (24). In this model, AMCase is
elicitedbyIL-13andisanessentialdownstreammediatorofIL-13
activity,includingtheinductionofeosinophiliaandairwayhyper-
reactivity (25). On the other hand, AMCase, by virtue of its chi-
tinolytic activity, has been reported to reduce allergic inﬂamma-
tion induced by chitin (12). Some studies, but not others, have
linked AMCase polymorphisms to asthma in humans (26, 27).
The nonchitinolytic chitinase YKL-40 has also been linked to al-
lergic inﬂammation. Mice genetically deﬁcient in YKL-40 exhibit
less allergic inﬂammation than do normal mice. Additional stud-
ies in this system suggest that YKL-40 promotes inﬂammation by
preventing the death of inﬂammatory cells (including eosino-
phils) and promoting alternative activation of macrophages (28).
In humans, YKL-40 levels are elevated in the serum and bron-
choalveolar lavage (BAL) ﬂuid of asthmatics (29). Furthermore,
increased YKL-40 levels correlated with asthma severity and are
elevated in response to allergen challenge (30). Thus, chitinases
appear to play a protective role in the innate response to fungal
infection but also mediate adaptive TH2 inﬂammation.
BREAKING THE MOLD: EMERGING CONCEPTS IN SEVERE
ASTHMA, FUNGAL INFECTION, AND CHITINASES
In concert with an increased understanding of chitinases in aller-
gic inﬂammation, there has been increased attention devoted to
the potential role of fungal infections in asthma. Fungal antigens
are an important cause of allergen-induced asthma. Sensitization
to fungal allergens is thought to occur as a result of transient,
repeated exposures without invasion or colonization of host tis-
sue. Nonetheless, it is well recognized that fungi can also elicit
asthma symptoms in association with persistent colonization or
superﬁcial invasion of host tissue. Airway colonization with
Aspergillus causes allergic bronchopulmonary aspergillosis
(ABPA) in patients with cystic ﬁbrosis or chronic asthma. While
ABPA is most commonly associated with A. fumigatus, other
Aspergillus species and fungi have been implicated (31–33).
Chronic fungal infections outside the respiratory tract (including
skin infections) can also exacerbate allergic symptoms (34, 35).
Together with our colleagues, we have explored the potential
contributionofongoingfungalinfectiontoasthmaandtheroleof
the chitinase pathway by using C. neoformans as a model patho-
gen. Because of its association with pigeon droppings, subclinical
infection with C. neoformans is common among individuals (in-
cluding children) living in an urban area (36). C. neoformans is
also well recognized for its tendency to cause persistent infections
(37–39) and allergic inﬂammation in animal models (40, 41).
CryptococcalvirulencehasbeenlinkedtoitscapacitytoelicitTH2
inﬂammation, which is mediated in part through IL-13 (42, 43).
In a rat model, persistent pulmonary C. neoformans infection is
associated with increased IL-13 levels and enhancement of many
of the features of asthma, including allergic inﬂammation, airway
FIG 1 Model of hypothesized role of chitinases in fungus-associated asthma. Mutations resulting in decreased activity of chitotriosidase confer increased
susceptibility to fungal infection, thereby contributing to increased asthma severity, possibly via enhanced induction of YKL-40.
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gal therapy ameliorates these effects.
IS THE CONNECTION BETWEEN PERSISTENT FUNGAL
INFECTION AND SEVERE ASTHMA RELATED TO ACTIVATION
OF THE CHITINASE PATHWAY?
While associations between fungal infection and asthma are well
described in the literature, they are frequently viewed as uncom-
monphenomenaorcoincidentalobservations.Recentdata,how-
ever, suggest that fungi may play a larger role, particularly in the
context of severe disease. A newly described subtype of asthma,
termedsevereasthmawithfungalsensitization(SAFS),highlights
the expanding awareness of fungi in asthma (45). SAFS—charac-
terized by failure of step 4 asthma therapy, elevated serum IgE
levels, and sensitization to one of several environmental fungi—
may represent one point on a spectrum of fungus-associated
asthma.Importantly,asthmacontrolisimprovedinSAFSpatients
usingprolongeditraconazoletherapy.Sincetheinitialdescription
of SAFS, numerous cases have been reported, but its true preva-
lence remains unknown. However, we recently demonstrated a
highprevalenceofSAFS(40%),aswellassigniﬁcantdifferences
in lung function, in a small cohort of severe asthmatics from the
greater New York City area (A. G. Vicencio, M. Tyberg, M. T.
Santiago, E. A. Foley, D. Bush, A. Casadevall, and D. L. Goldman,
submitted for publication). In addition, we previously demon-
strated increased IgA and IgG reactivity to fungal proteins in the
bronchoalveolar lavage ﬂuid of children with severe asthma (46).
Hence, the contribution of fungi to the development and persis-
tence of asthma may be underestimated.
Although the precise mechanisms underlying fungus-
associated asthma remain unclear, emerging evidence suggests a
potential role for chitinases. We propose that fungus-associated
asthma could represent an imbalance between chitinolytic and
nonchitinolytic chitinases. Speciﬁcally, we hypothesize that mu-
tations resulting in decreased activity of chitotriosidase confer in-
creased susceptibility to fungal infection, thereby contributing to
increased asthma severity, possibly via enhanced induction of
YKL-40 (Fig. 1). In support of this hypothesis, we previously de-
scribed 6 children who ﬁtted modiﬁed pediatric criteria for SAFS,
allofwhomwereheterozygousfora24-bpduplicationinCHIT1,
which results in a 50% decrease in enzymatic activity (47). In
further support, polymorphisms in CHIT1 have been associated
with asthma exacerbations in children but are dependent on en-
vironmental fungal burden (48). Certainly, additional studies are
warranted to more precisely deﬁne the complex interactions be-
tween host chitinases, fungal exposures, and subsequent inﬂam-
matory responses in the airway.
SUMMARY
Chitin and its derivatives may represent a critical link between
fungal pathogens and their interactions with the environment.
Host responses to this important polysaccharide may depend in
partoncomplexinteractionsbetweenfungalchitinandhostchiti-
nases. Future studies focusing on not only the role of chitin in
fungal pathogenesis but also the host response to the polysaccha-
ride will hopefully strengthen the “chitin connection.”
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